Next Article in Journal
In Vivo PK-PD and Drug–Drug Interaction Study of Dorzagliatin for the Management of PI3Kα Inhibitor-Induced Hyperglycemia
Previous Article in Journal
3D-QSAR Design of New Bcr-Abl Inhibitors Based on Purine Scaffold and Cytotoxicity Studies on CML Cell Lines Sensitive and Resistant to Imatinib
Previous Article in Special Issue
Ceftriaxone-Loaded Liposomal Nanoparticles for Pulmonary Delivery Against Lower Respiratory Tract Infections: Development and Characterization
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(6), 923; https://doi.org/10.3390/ph18060923
Action Date Notes Link
article xml file uploaded 19 June 2025 12:08 CEST Original file -
article xml uploaded. 19 June 2025 12:08 CEST Update https://www.mdpi.com/1424-8247/18/6/923/xml
article pdf uploaded. 19 June 2025 12:08 CEST Version of Record https://www.mdpi.com/1424-8247/18/6/923/pdf
article html file updated 19 June 2025 12:11 CEST Original file https://www.mdpi.com/1424-8247/18/6/923/html
Back to TopTop